For research use only. Not for therapeutic Use.
S1R agonist 2（Cat No.:I041189）is an investigational compound being developed to target the sigma-1 receptor (S1R), a protein involved in regulating cellular stress response, neuroprotection, and immune modulation. By activating the S1R, this compound aims to enhance neuronal survival, reduce inflammation, and protect cells from damage in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. Preclinical studies have shown that S1R agonist 2 may help mitigate oxidative stress and improve cognitive function. Ongoing clinical research is evaluating its safety, efficacy, and potential therapeutic benefits in treating neurodegenerative and inflammatory conditions.
| CAS Number | 150085-21-5 |
| Synonyms | 4-benzyl-1-(3-phenoxypropyl)piperidine |
| Molecular Formula | C21H27NO |
| Purity | ≥95% |
| IUPAC Name | 4-benzyl-1-(3-phenoxypropyl)piperidine |
| InChI | InChI=1S/C21H27NO/c1-3-8-19(9-4-1)18-20-12-15-22(16-13-20)14-7-17-23-21-10-5-2-6-11-21/h1-6,8-11,20H,7,12-18H2 |
| InChIKey | KOYQYIAABUPJFF-UHFFFAOYSA-N |
| SMILES | C1CN(CCC1CC2=CC=CC=C2)CCCOC3=CC=CC=C3 |
